Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Unlike HGH, AOD-9604 does not affect insulin-like growth factor 1 (IGF-1) levels, meaning it does not have the same potential side effects as HGH, such as promoting cell growth or affecting blood sugar levels
These injections are non-toxic, they repair nerves, they have a profound effect on the management of pernicious anemia, and theyre not expensive at all
The ice crystal formation during freezing can physically damage peptide structures and significantly reduce potency
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
